annual FCF:
$13.94B+$1.29B(+10.20%)Summary
- As of today (April 16, 2025), BMY annual free cash flow is $13.94 billion, with the most recent change of +$1.29 billion (+10.20%) on December 1, 2024.
- During the last 3 years, BMY annual FCF has fallen by -$1.29 billion (-8.48%).
- BMY annual FCF is now -8.48% below its all-time high of $15.23 billion, reached on December 31, 2021.
Performance
BMY Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$4.06B-$1.21B(-22.90%)Summary
- As of today (April 16, 2025), BMY quarterly free cash flow is $4.06 billion, with the most recent change of -$1.21 billion (-22.90%) on December 1, 2024.
- Over the past year, BMY quarterly FCF has increased by +$139.00 million (+3.54%).
- BMY quarterly FCF is now -22.90% below its all-time high of $5.27 billion, reached on September 30, 2024.
Performance
BMY quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$13.94B+$139.00M(+1.01%)Summary
- As of today (April 16, 2025), BMY TTM free cash flow is $13.94 billion, with the most recent change of +$139.00 million (+1.01%) on December 1, 2024.
- Over the past year, BMY TTM FCF has increased by +$1.29 billion (+10.20%).
- BMY TTM FCF is now -8.48% below its all-time high of $15.23 billion, reached on December 31, 2021.
Performance
BMY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BMY Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10.2% | +3.5% | +10.2% |
3 y3 years | -8.5% | +3.5% | +10.2% |
5 y5 years | +89.1% | +3.5% | +10.2% |
BMY Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -8.5% | +16.7% | -22.9% | +149.4% | -7.9% | +30.1% |
5 y | 5-year | -8.5% | +89.1% | -22.9% | +149.4% | -8.5% | +40.3% |
alltime | all time | -8.5% | +5982.7% | -22.9% | +413.1% | -8.5% | +5982.7% |
Bristol-Myers Squibb Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $13.94B(+10.2%) | $4.06B(-22.9%) | $13.94B(+1.0%) |
Sep 2024 | - | $5.27B(+155.2%) | $13.80B(+6.6%) |
Jun 2024 | - | $2.06B(-19.1%) | $12.95B(+3.5%) |
Mar 2024 | - | $2.55B(-35.0%) | $12.51B(-1.1%) |
Dec 2023 | $12.65B(+5.9%) | $3.92B(-11.0%) | $12.65B(+8.2%) |
Sep 2023 | - | $4.41B(+170.8%) | $11.69B(+9.0%) |
Jun 2023 | - | $1.63B(-39.5%) | $10.72B(-3.3%) |
Mar 2023 | - | $2.69B(-9.1%) | $11.08B(-7.3%) |
Dec 2022 | $11.95B(-21.6%) | $2.96B(-14.0%) | $11.95B(-6.1%) |
Sep 2022 | - | $3.44B(+73.0%) | $12.72B(-10.9%) |
Jun 2022 | - | $1.99B(-44.1%) | $14.28B(-5.7%) |
Mar 2022 | - | $3.56B(-4.8%) | $15.14B(-0.6%) |
Dec 2021 | $15.23B(+14.5%) | $3.74B(-25.2%) | $15.23B(+4.6%) |
Sep 2021 | - | $5.00B(+75.3%) | $14.57B(+24.7%) |
Jun 2021 | - | $2.85B(-21.9%) | $11.69B(-11.5%) |
Mar 2021 | - | $3.65B(+18.8%) | $13.20B(-0.8%) |
Dec 2020 | $13.30B(+80.3%) | $3.07B(+45.3%) | $13.30B(+9.4%) |
Sep 2020 | - | $2.11B(-51.5%) | $12.16B(-2.0%) |
Jun 2020 | - | $4.36B(+16.3%) | $12.41B(+24.9%) |
Mar 2020 | - | $3.75B(+94.4%) | $9.94B(+34.8%) |
Dec 2019 | $7.37B(+20.6%) | $1.93B(-18.4%) | $7.37B(-15.3%) |
Sep 2019 | - | $2.37B(+25.1%) | $8.71B(+17.7%) |
Jun 2019 | - | $1.89B(+59.5%) | $7.40B(+16.2%) |
Mar 2019 | - | $1.19B(-63.7%) | $6.37B(+4.1%) |
Dec 2018 | $6.12B(+44.9%) | $3.27B(+209.5%) | $6.12B(+64.7%) |
Sep 2018 | - | $1.05B(+22.8%) | $3.71B(-9.6%) |
Jun 2018 | - | $859.00M(-8.2%) | $4.11B(-10.4%) |
Mar 2018 | - | $936.00M(+8.5%) | $4.59B(+8.7%) |
Dec 2017 | $4.22B(+129.0%) | $863.00M(-40.5%) | $4.22B(-4.7%) |
Sep 2017 | - | $1.45B(+8.6%) | $4.43B(+9.6%) |
Jun 2017 | - | $1.34B(+134.4%) | $4.04B(+40.2%) |
Mar 2017 | - | $570.00M(-46.8%) | $2.88B(+56.4%) |
Dec 2016 | $1.84B(+43.4%) | $1.07B(+0.8%) | $1.84B(+34.5%) |
Sep 2016 | - | $1.06B(+497.2%) | $1.37B(+129.5%) |
Jun 2016 | - | $178.00M(-137.9%) | $597.00M(+83.7%) |
Mar 2016 | - | -$470.00M(-178.5%) | $325.00M(-74.7%) |
Dec 2015 | $1.28B(-51.0%) | $599.00M(+106.6%) | $1.28B(+20.4%) |
Sep 2015 | - | $290.00M(-408.5%) | $1.07B(-32.2%) |
Jun 2015 | - | -$94.00M(-119.2%) | $1.57B(-39.8%) |
Mar 2015 | - | $490.00M(+28.6%) | $2.61B(-0.3%) |
Dec 2014 | $2.62B(-12.8%) | $381.00M(-52.1%) | $2.62B(-24.0%) |
Sep 2014 | - | $796.00M(-15.9%) | $3.45B(-3.7%) |
Jun 2014 | - | $946.00M(+89.6%) | $3.58B(-11.5%) |
Mar 2014 | - | $499.00M(-58.8%) | $4.05B(+34.6%) |
Dec 2013 | $3.01B(-52.9%) | $1.21B(+30.2%) | $3.01B(+22.3%) |
Sep 2013 | - | $929.00M(-34.2%) | $2.46B(-58.9%) |
Jun 2013 | - | $1.41B(-360.0%) | $5.98B(+7.0%) |
Mar 2013 | - | -$543.00M(-182.1%) | $5.59B(-12.6%) |
Dec 2012 | $6.39B(+42.9%) | $661.00M(-85.1%) | $6.39B(-10.8%) |
Sep 2012 | - | $4.45B(+335.6%) | $7.17B(+65.4%) |
Jun 2012 | - | $1.02B(+286.7%) | $4.33B(+0.0%) |
Mar 2012 | - | $264.00M(-81.6%) | $4.33B(-3.2%) |
Dec 2011 | $4.47B(+10.0%) | $1.43B(-11.2%) | $4.47B(-0.8%) |
Sep 2011 | - | $1.61B(+58.4%) | $4.51B(+7.6%) |
Jun 2011 | - | $1.02B(+151.0%) | $4.19B(+1.2%) |
Mar 2011 | - | $406.00M(-72.4%) | $4.14B(+1.7%) |
Dec 2010 | $4.07B(+21.9%) | $1.47B(+13.6%) | $4.07B(+8.6%) |
Sep 2010 | - | $1.29B(+33.7%) | $3.75B(-0.3%) |
Jun 2010 | - | $968.00M(+189.0%) | $3.75B(+9.8%) |
Mar 2010 | - | $335.00M(-70.8%) | $3.42B(+2.5%) |
Dec 2009 | $3.33B(+20.6%) | $1.15B(-12.0%) | $3.33B(+47.0%) |
Sep 2009 | - | $1.30B(+106.3%) | $2.27B(+2.2%) |
Jun 2009 | - | $632.00M(+151.8%) | $2.22B(-10.9%) |
Mar 2009 | - | $251.00M(+209.9%) | $2.49B(-9.9%) |
Dec 2008 | $2.77B(+19.7%) | $81.00M(-93.6%) | $2.77B(-9.8%) |
Sep 2008 | - | $1.26B(+38.9%) | $3.06B(+32.1%) |
Jun 2008 | - | $904.00M(+72.2%) | $2.32B(+2.2%) |
Mar 2008 | - | $525.00M(+38.2%) | $2.27B(-1.6%) |
Dec 2007 | $2.31B | $380.00M(-25.8%) | $2.31B(+20.6%) |
Sep 2007 | - | $512.00M(-40.1%) | $1.92B(-10.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2007 | - | $855.00M(+51.9%) | $2.15B(+8.9%) |
Mar 2007 | - | $563.00M(-3853.3%) | $1.97B(+52.9%) |
Dec 2006 | $1.29B(+20.8%) | -$15.00M(-102.0%) | $1.29B(-7.8%) |
Sep 2006 | - | $744.00M(+9.4%) | $1.40B(+13.8%) |
Jun 2006 | - | $680.00M(-671.4%) | $1.23B(+254.2%) |
Mar 2006 | - | -$119.00M(-226.6%) | $347.00M(-67.5%) |
Dec 2005 | $1.07B(-54.9%) | $94.00M(-83.6%) | $1.07B(-26.5%) |
Sep 2005 | - | $574.00M(-384.2%) | $1.45B(+25.6%) |
Jun 2005 | - | -$202.00M(-133.6%) | $1.16B(-43.5%) |
Mar 2005 | - | $602.00M(+25.4%) | $2.05B(-13.4%) |
Dec 2004 | $2.37B(-6.1%) | $480.00M(+72.7%) | $2.37B(-15.7%) |
Sep 2004 | - | $278.00M(-59.8%) | $2.81B(-13.2%) |
Jun 2004 | - | $691.00M(-24.7%) | $3.23B(-7.4%) |
Mar 2004 | - | $918.00M(-0.4%) | $3.49B(+38.5%) |
Dec 2003 | $2.52B(-1164.1%) | $922.00M(+31.0%) | $2.52B(+38.6%) |
Sep 2003 | - | $704.00M(-25.8%) | $1.82B(+0.2%) |
Jun 2003 | - | $949.00M(-1890.6%) | $1.82B(+80.3%) |
Mar 2003 | - | -$53.00M(-124.1%) | $1.01B(-524.9%) |
Dec 2002 | -$237.00M(-105.4%) | $220.00M(-68.6%) | -$237.00M(-120.2%) |
Sep 2002 | - | $700.00M(+400.0%) | $1.17B(-6.2%) |
Jun 2002 | - | $140.00M(-110.8%) | $1.25B(-47.7%) |
Mar 2002 | - | -$1.30B(-179.6%) | $2.39B(-45.5%) |
Dec 2001 | $4.38B(+7.8%) | $1.63B(+109.8%) | $4.38B(+1.6%) |
Sep 2001 | - | $777.00M(-39.2%) | $4.31B(-5.9%) |
Jun 2001 | - | $1.28B(+84.1%) | $4.58B(+10.6%) |
Mar 2001 | - | $694.00M(-55.6%) | $4.14B(+1.9%) |
Dec 2000 | $4.06B(+15.6%) | $1.56B(+48.9%) | $4.06B(+7.0%) |
Sep 2000 | - | $1.05B(+25.3%) | $3.80B(+3.2%) |
Jun 2000 | - | $837.00M(+36.1%) | $3.68B(+4.2%) |
Mar 2000 | - | $615.00M(-52.5%) | $3.53B(+0.5%) |
Dec 1999 | $3.52B(+17.4%) | $1.30B(+39.1%) | $3.52B(+14.4%) |
Sep 1999 | - | $932.00M(+35.5%) | $3.07B(-6.5%) |
Jun 1999 | - | $688.00M(+14.9%) | $3.29B(+14.7%) |
Mar 1999 | - | $599.00M(-29.9%) | $2.87B(-4.2%) |
Dec 1998 | $2.99B(+75.2%) | $854.00M(-25.5%) | $2.99B(+24.5%) |
Sep 1998 | - | $1.15B(+329.6%) | $2.40B(+25.7%) |
Jun 1998 | - | $267.00M(-63.2%) | $1.91B(+2.4%) |
Mar 1998 | - | $726.00M(+175.0%) | $1.87B(+9.4%) |
Dec 1997 | $1.71B(-16.2%) | $264.00M(-59.8%) | $1.71B(-9.6%) |
Sep 1997 | - | $656.00M(+194.2%) | $1.89B(+2.8%) |
Jun 1997 | - | $223.00M(-60.6%) | $1.84B(-12.7%) |
Mar 1997 | - | $566.00M(+27.2%) | $2.11B(+3.2%) |
Dec 1996 | $2.04B(+2.7%) | $445.00M(-26.3%) | $2.04B(-0.8%) |
Sep 1996 | - | $604.00M(+23.0%) | $2.06B(-2.0%) |
Jun 1996 | - | $491.00M(-1.8%) | $2.10B(+15.0%) |
Mar 1996 | - | $500.00M(+8.5%) | $1.82B(-8.2%) |
Dec 1995 | $1.99B(+14.9%) | $461.00M(-28.5%) | $1.99B(-0.1%) |
Sep 1995 | - | $645.00M(+197.2%) | $1.99B(+18.0%) |
Jun 1995 | - | $217.00M(-67.3%) | $1.69B(-6.5%) |
Mar 1995 | - | $663.00M(+43.2%) | $1.80B(+4.3%) |
Dec 1994 | $1.73B(-14.0%) | $463.00M(+35.4%) | $1.73B(-4.8%) |
Sep 1994 | - | $342.00M(+2.4%) | $1.82B(-15.6%) |
Jun 1994 | - | $334.00M(-43.3%) | $2.15B(-6.1%) |
Mar 1994 | - | $589.00M(+6.9%) | $2.29B(+14.0%) |
Dec 1993 | $2.01B(+45.5%) | $551.00M(-18.7%) | $2.01B(+4.9%) |
Sep 1993 | - | $678.00M(+43.3%) | $1.92B(+8.6%) |
Jun 1993 | - | $473.00M(+53.6%) | $1.76B(+24.9%) |
Mar 1993 | - | $308.00M(-32.8%) | $1.41B(+2.3%) |
Dec 1992 | $1.38B(+14.4%) | $458.00M(-12.9%) | $1.38B(+2.1%) |
Sep 1992 | - | $526.00M(+334.7%) | $1.35B(+14.0%) |
Jun 1992 | - | $121.00M(-56.2%) | $1.19B(-2.6%) |
Mar 1992 | - | $276.00M(-35.7%) | $1.22B(+0.9%) |
Dec 1991 | $1.21B(-2.6%) | $429.00M(+19.2%) | $1.21B(+4.8%) |
Sep 1991 | - | $360.00M(+135.3%) | $1.15B(+2.3%) |
Jun 1991 | - | $153.00M(-42.3%) | $1.13B(-8.9%) |
Mar 1991 | - | $265.00M(-29.1%) | $1.24B(-0.2%) |
Dec 1990 | $1.24B(+95.1%) | $374.00M(+12.0%) | $1.24B(+43.2%) |
Sep 1990 | - | $334.00M(+27.0%) | $865.00M(+62.9%) |
Jun 1990 | - | $263.00M(-1.9%) | $531.00M(+98.1%) |
Mar 1990 | - | $268.00M | $268.00M |
Dec 1989 | $635.00M | - | - |
FAQ
- What is Bristol-Myers Squibb annual free cash flow?
- What is the all time high annual FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual FCF year-on-year change?
- What is Bristol-Myers Squibb quarterly free cash flow?
- What is the all time high quarterly FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly FCF year-on-year change?
- What is Bristol-Myers Squibb TTM free cash flow?
- What is the all time high TTM FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM FCF year-on-year change?
What is Bristol-Myers Squibb annual free cash flow?
The current annual FCF of BMY is $13.94B
What is the all time high annual FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual free cash flow is $15.23B
What is Bristol-Myers Squibb annual FCF year-on-year change?
Over the past year, BMY annual free cash flow has changed by +$1.29B (+10.20%)
What is Bristol-Myers Squibb quarterly free cash flow?
The current quarterly FCF of BMY is $4.06B
What is the all time high quarterly FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly free cash flow is $5.27B
What is Bristol-Myers Squibb quarterly FCF year-on-year change?
Over the past year, BMY quarterly free cash flow has changed by +$139.00M (+3.54%)
What is Bristol-Myers Squibb TTM free cash flow?
The current TTM FCF of BMY is $13.94B
What is the all time high TTM FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM free cash flow is $15.23B
What is Bristol-Myers Squibb TTM FCF year-on-year change?
Over the past year, BMY TTM free cash flow has changed by +$1.29B (+10.20%)